Effects of peptide and non-peptide antagonists of angiotensin II receptors on drinking behavior in rats

被引:13
作者
Alova, LG
Stancheva, SL
Matsoukas, J
Georgiev, VP
机构
[1] Bulgarian Acad Sci, Inst Physiol, Radioizotope Lab, Sofia 1113, Bulgaria
[2] Bulgarian Acad Sci, Inst Physiol, Lab Expt Psychopharmacol, Sofia 1113, Bulgaria
[3] Univ Patras, Dept Chem, Patras 26500, Greece
关键词
angiotensin II-induced drinking; angiotensin AT(1) receptor antagonists (DuP 753; EXP; 3174; saralasin; sarmesin); 1-methyl-4,5-diphenylimidazole;
D O I
10.1016/S0928-4257(99)80154-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of the non-peptide selective angiotensin II AT, receptor antagonist DuP 753 and its metabolite EXP 3174, of the peptide ANGII analogues saralasin and sarmesin and of the newly synthesized imidazole compound (1-methyl-4,5-diphenylimidazole) on ANGII-induced drinking in rats were investigated. The effect of the AT, selective antagonist PD 123319 on ANGII-induced drinking in rats was also studied. DuP 753, EXP 3174, saralasin and sarmesin (peptides and non-peptides) dose-dependently inhibited ANGII-induced water intake. The ID50 values of these drugs showed the following order of potency: EXP 3174 > saralasin > sarmesin > DuP 753 indicating their ability to block central AT(1) receptors. The imidazole compound increased ANGII-induced water intake suggesting its AT(1) receptor agonistic properties. PD 123319 inhibited ANGII-induced water intake at a higher dose (64 nmol), allowing to assume AT(1) receptor agonistic properties. (C) Elsevier, Paris.
引用
收藏
页码:219 / 224
页数:6
相关论文
共 22 条
[1]   NOMENCLATURE FOR ANGIOTENSIN RECEPTORS - A REPORT OF THE NOMENCLATURE-COMMITTEE OF THE COUNCIL-FOR-HIGH-BLOOD-PRESSURE-RESEARCH [J].
BUMPUS, FM ;
CATT, KJ ;
CHIU, AT ;
DEGASPARO, M ;
GOODFRIEND, T ;
HUSAIN, A ;
PEACH, MJ ;
TAYLOR, DG ;
TIMMERMANS, PBMWM .
HYPERTENSION, 1991, 17 (05) :720-721
[2]  
CHIU AT, 1993, CELLULAR MOL BIOL RE, P245
[3]   DRINKING INDUCED BY SUBCUTANEOUS INJECTION OF ANGIOTENSIN-II IN THE RAT IS BLOCKED BY THE SELECTIVE AT(1) RECEPTOR ANTAGONIST DUP-753 BUT NOT BY THE SELECTIVE AT(2) RECEPTOR ANTAGONIST WL-19 [J].
DOURISH, CT ;
DUGGAN, JA ;
BANKS, RJA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 211 (01) :113-116
[4]  
Fitzsimons J T, 1980, Rev Physiol Biochem Pharmacol, V87, P117, DOI 10.1007/BFb0030897
[5]   PEPTIDE ANTAGONISTS OF RENIN-ANGIOTENSIN SYSTEM IN CHARACTERIZATION OF RECEPTORS FOR ANGIOTENSIN-INDUCED DRINKING [J].
FITZSIMONS, JT ;
EPSTEIN, AN ;
JOHNSON, AK .
BRAIN RESEARCH, 1978, 153 (02) :319-331
[6]   EFFECT ON DRINKING IN RAT OF INTRAVENOUS INFUSION OF ANGIOTENSIN, GIVEN ALONE OR IN COMBINATION WITH OTHER STIMULI OF THIRST [J].
FITZSIMONS, JT ;
SIMONS, BJ .
JOURNAL OF PHYSIOLOGY-LONDON, 1969, 203 (01) :45-+
[7]  
FITZSIMONS JT, 1986, PHYSL THIRST SODIUM, P386
[8]   EFFECT OF A NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, DUP-753, ON ANGIOTENSIN-RELATED WATER-INTAKE IN RATS [J].
FREGLY, MJ ;
ROWLAND, NE .
BRAIN RESEARCH BULLETIN, 1991, 27 (01) :97-100
[9]   Influence of sarmesin on some dopamine-related types of behaviour [J].
Georgiev, V ;
Matsoukas, JM ;
Georgieva, D ;
Tchekalarova, J ;
Todorov, I .
LETTERS IN PEPTIDE SCIENCE, 1996, 3 (04) :185-190
[10]  
Georgiev Vasil, 1992, Kurume Medical Journal, V39, P235